A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin-2 in metastatic malignant melanoma

Subcutaneous interleukin-2 and interferon-α plus cisplatin with and without prophylactic cimetidine in patients with metastatic malignant melanoma: a phase II study

Melanoma Research ◽

10.1097/00008390-200002000-00009 ◽

2000 ◽

Vol 10 (1) ◽

pp. 66-77

Author(s):

H. Schmidt ◽

P. F. Geertsen ◽

K. Fode ◽

C. Rytter ◽

L. Bastholt ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Interleukin 2 ◽

Interferon Α

Subcutaneous interleukin-2 and interferon-α plus cisplatin with and without prophylactic cimetidine in patients with metastatic malignant melanoma: a phase II study

Melanoma Research ◽

10.1097/00008390-200010010-00009 ◽

2000 ◽

Vol 10 (1) ◽

pp. 66-77 ◽

Cited By ~ 11

Author(s):

H. Schmidt ◽

P. F. Geertsen ◽

K. Fode ◽

C. Rytter ◽

L. Bastholt ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Interleukin 2 ◽

Interferon Α

Phase II study of fotemustine (F), cisplatin (CDDP), and tamoxifen (TAM) in metastatic malignant melanoma (MMM)

Melanoma Research ◽

10.1097/00008390-199303000-00115 ◽

1993 ◽

Vol 3 (1) ◽

pp. 34

Author(s):

K. A. Semb ◽

S. Aamdal ◽

T. Bohmann ◽

C. Lucas ◽

B. Gerard

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Clinical and pharmacokinetic phase II study of fotemustine(F), cisplatin (C) and high-dose tamoxifen (T) in metastatic malignant melanoma (MMM)

Melanoma Research ◽

10.1097/00008390-199706001-00026 ◽

1997 ◽

Vol 7 (Supplement 1) ◽

pp. S8

Author(s):

K A Semb ◽

S Aamdal ◽

T Bohmann ◽

C Lucas ◽

B Gerard

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

High Dose

A phase II study of DuP 937 (Teloxantrone) in metastatic malignant melanoma: A study of the National Cancer Institute of Canada Clinical Trials Group (NCICCTG)

Annals of Oncology ◽

10.1093/oxfordjournals.annonc.a058628 ◽

1993 ◽

Vol 4 (8) ◽

pp. 695-696

Author(s):

T. Shore ◽

E. Eisenhauer ◽

I. Quirt ◽

K. Belanger ◽

R. Lohmann ◽

...

Keyword(s):

Clinical Trials ◽

Malignant Melanoma ◽

Phase Ii ◽

National Cancer Institute ◽

Phase Ii Study ◽

A phase II study of bryostatin 1 in metastatic malignant melanoma

British Journal of Cancer ◽

10.1038/bjc.1998.680 ◽

1998 ◽

Vol 78 (10) ◽

pp. 1337-1341 ◽

Cited By ~ 56

Author(s):

DJ Propper ◽

V Macaulay ◽

KJ O'Byrne ◽

JP Braybrooke ◽

SM Wilner ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Bryostatin 1

A phase II study of bortezomib in the treatment of metastatic malignant melanoma

Cancer ◽

10.1002/cncr.21108 ◽

2005 ◽

Vol 103 (12) ◽

pp. 2584-2589 ◽

Cited By ~ 89

Author(s):

Svetomir N. Markovic ◽

Susan M. Geyer ◽

Fitzroy Dawkins ◽

William Sharfman ◽

Mark Albertini ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Phase II study of thalidomide in patients with metastatic malignant melanoma

Melanoma Research ◽

10.1097/00008390-200412000-00014 ◽

2004 ◽

Vol 14 (6) ◽

pp. 527-531 ◽

Cited By ~ 31

Author(s):

Andr?? B. Reiriz ◽

Marc F. Richter ◽

Sabrina Fernandes ◽

Anna I. Cancela ◽

Teresa D. Costa ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

A phase II study of CCNU with benznidazole for metastatic malignant melanoma

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/0360-3016(86)90181-1 ◽

1986 ◽

Vol 12 (8) ◽

pp. 1401-1403 ◽

Cited By ~ 10

Author(s):

Norman M. Bleehen ◽

J. Trevor Roberts ◽

Hugh F.V. Newman

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

A multicentre, dose finding, phase II study of CP-4055 in combination with sorafenib in patients with metastatic malignant melanoma

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.20029 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 20029-20029

Author(s):

S. Dueland ◽

S. Aamdal ◽

L. Lundgren ◽

G. Wagenius ◽

J. Sarantopoulos ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Dose Finding